Search results

• Finished

  Examining IL-36 signaling as a therapeutic target in pustular psoriasis

  Capon, F. & Smith, C.

  Boehringer Ingelheim GmbH

  1/10/2018 → 30/09/2022

  Project: Research

• Clinical, genetic and immune determinants of drug immunogenicity in psoriasis

  Smith, C., Tsakok, T., Simpson, M. & Spencer, J.

  MRC Medical Research Council

  1/10/2017 → 7/06/2023

  Project: Research

• Investigating the role of abnormal IL-1 signalling in palmar-plantar pustulosis (PPP), a genetic approach

  Capon, F., Barker, J. & Smith, C.

  1/10/2015 → 30/09/2018

  Project: Research

• Psoriasis Stratification to Optimise Relevant Therapy (PSORT)

  Barker, J., Capon, F., Nestle, F., Simpson, M., Smith, C. & Di Meglio, P.

  MRC Medical Research Council

  7/04/2014 → 31/05/2021

  Project: Research

  • Combination Therapy 100%
  • Psoriasis 100%

• A multi-centre, prospective, cohort study to establish clinically relevant pharmaco-genetic markers of systemic treatment outcomes in patients with severe psoriasis

  Smith, C., Barker, J., Burden, D., Griffiths, C., Knight, J., Ormerod, T., Richard, W. & Simpson, M.

  Psoriasis Association

  19/12/2010 → 1/10/2014

  Project: Research

• A multi-centre, prospective, cohort study to establish clinically relevant pharmaco-genetic markers of systemic treatment outcomes in patients with severe psoriasis

  Smith, C., Barker, J., Reynolds, N., Richard, W., Trembath, R. & Weale, M.

  1/11/2009 → 31/10/2011

  Project: Research

• British Association of Dermatologists' biological intervention register

  Barker, J. & Smith, C.

  British Association of Dermatologists

  1/08/2008 → 31/07/2013

  Project: Research

• A molecular genetic investigation of acne vulgaris: identification of susceptibility genes relevant to disease pathogenesis.

  Smith, C., Barker, J., Bataille, V., Burden, D., Leyton, A., Spector, T., Trembath, R. & Zahradnik, D. R.

  British Skin Foundation

  1/11/2007 → 31/03/2010

  Project: Research

• Predicting drug response: Investigations into the pharmacogenetic basis of the safety and efficacy of systemic therapies used in the treatment of moderate to severe psoriasis

  Smith, C. & Solomon, E.

  National Psoriasis Foundation

  1/04/2004 → 31/03/2006

  Project: Research

• Apoliprotein E polymorphisms, chronic plaque psoriasis and disease response to acitretin

  Smith, C. & Solomon, E.

  Psoriasis Association

  1/06/2003 → 31/05/2004

  Project: Research

• A Randomised, Placebo-controlled, Double-blind study to evaluate the Safety and Efficacy of Hydroxyurea in Chronic Plaque Psoriasis using a Novel Dosing Schedule

  Barker, J. & Smith, C.

  Guy's & St Thomas' Charity

  1/06/2002 → 31/05/2003

  Project: Research

• A randomised, placebo-controlled, double-blind study to evaluate the safety and efficacy of hydroxyurea in chronic plaque psoriasis using a novel dosing schedule

  Smith, C. & Solomon, E.

  British Skin Foundation

  1/06/2001 → 31/05/2002

  Project: Research

• Studies to formally evaluate topical preparations of unproven therapeutic benefit that are available for treatment of chronic plaque psoriasis.

  Smith, C. & Solomon, E.

  St John's Dermatological Society

  1/10/1998 → 30/09/1999

  Project: Research